Commensal Escherichia coliStrains can promote intestinal inflammation via differential interleukin-6 production

Hatem Kittana, João Carlos Gomes-Neto, Kari Heck, Abby L. Geis, Rafael R. Segura Muñoz, Liz A. Cody, Robert J. Schmaltz, Laure B. Bindels, Rohita Sinha, Jesse M. Hostetter, Andrew K. Benson, Amanda E. Ramer-Tait

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Escherichia coli is a facultative anaerobic symbiont found widely among mammalian gastrointestinal tracts. Several human studies have reported increased commensal E. coli abundance in the intestine during inflammation; however, host immunological responses toward commensal E. coli during inflammation are not well-defined. Here, we show that colonization of gnotobiotic mice with different genotypes of commensal E. coli isolated from healthy conventional microbiota mice and representing distinct populations of E. coli elicited strain-specific disease phenotypes and immunopathological changes following treatment with the inflammatory stimulus, dextran sulfate sodium (DSS). Production of the inflammatory cytokines GM-CSF, IL-6, and IFN-γ was a hallmark of the severe inflammation induced by E. coli strains of Sequence Type 129 (ST129) and ST375 following DSS administration. In contrast, colonization with E. coli strains ST150 and ST468 caused mild intestinal inflammation and triggered only low levels of pro-inflammatory cytokines, a response indistinguishable from that of E. coli-free control mice treated with DSS. The disease development observed with ST129 and ST375 colonization was not directly associated with their abundance in the GI tract as their levels did not change throughout DSS treatment, and no major differences in bacterial burden in the gut were observed among the strains tested. Data mining and in vivo neutralization identified IL-6 as a key cytokine responsible for the observed differential disease severity. Collectively, our results show that the capacity to exacerbate acute intestinal inflammation is a strain-specific trait that can potentially be overcome by blocking the pro-inflammatory immune responses that mediate intestinal tissue damage.

Original languageEnglish (US)
Article number2318
JournalFrontiers in immunology
Volume9
Issue numberOCT
DOIs
StatePublished - Oct 9 2018

Fingerprint

Escherichia
Interleukin-6
Escherichia coli
Inflammation
Dextran Sulfate
Cytokines
Gastrointestinal Tract
Germ-Free Life
Data Mining
Microbiota
Granulocyte-Macrophage Colony-Stimulating Factor
Intestines
Genotype
Phenotype

Keywords

  • Commensal e. coli
  • Gnotobiotic mice
  • Interleukin-6
  • Intestinal inflammation
  • Strain-specific immune responses

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Commensal Escherichia coliStrains can promote intestinal inflammation via differential interleukin-6 production. / Kittana, Hatem; Gomes-Neto, João Carlos; Heck, Kari; Geis, Abby L.; Segura Muñoz, Rafael R.; Cody, Liz A.; Schmaltz, Robert J.; Bindels, Laure B.; Sinha, Rohita; Hostetter, Jesse M.; Benson, Andrew K.; Ramer-Tait, Amanda E.

In: Frontiers in immunology, Vol. 9, No. OCT, 2318, 09.10.2018.

Research output: Contribution to journalArticle

Kittana, H, Gomes-Neto, JC, Heck, K, Geis, AL, Segura Muñoz, RR, Cody, LA, Schmaltz, RJ, Bindels, LB, Sinha, R, Hostetter, JM, Benson, AK & Ramer-Tait, AE 2018, 'Commensal Escherichia coliStrains can promote intestinal inflammation via differential interleukin-6 production', Frontiers in immunology, vol. 9, no. OCT, 2318. https://doi.org/10.3389/fimmu.2018.02318
Kittana, Hatem ; Gomes-Neto, João Carlos ; Heck, Kari ; Geis, Abby L. ; Segura Muñoz, Rafael R. ; Cody, Liz A. ; Schmaltz, Robert J. ; Bindels, Laure B. ; Sinha, Rohita ; Hostetter, Jesse M. ; Benson, Andrew K. ; Ramer-Tait, Amanda E. / Commensal Escherichia coliStrains can promote intestinal inflammation via differential interleukin-6 production. In: Frontiers in immunology. 2018 ; Vol. 9, No. OCT.
@article{62ef42b39e8142489ee0b59ed3ea77d9,
title = "Commensal Escherichia coliStrains can promote intestinal inflammation via differential interleukin-6 production",
abstract = "Escherichia coli is a facultative anaerobic symbiont found widely among mammalian gastrointestinal tracts. Several human studies have reported increased commensal E. coli abundance in the intestine during inflammation; however, host immunological responses toward commensal E. coli during inflammation are not well-defined. Here, we show that colonization of gnotobiotic mice with different genotypes of commensal E. coli isolated from healthy conventional microbiota mice and representing distinct populations of E. coli elicited strain-specific disease phenotypes and immunopathological changes following treatment with the inflammatory stimulus, dextran sulfate sodium (DSS). Production of the inflammatory cytokines GM-CSF, IL-6, and IFN-γ was a hallmark of the severe inflammation induced by E. coli strains of Sequence Type 129 (ST129) and ST375 following DSS administration. In contrast, colonization with E. coli strains ST150 and ST468 caused mild intestinal inflammation and triggered only low levels of pro-inflammatory cytokines, a response indistinguishable from that of E. coli-free control mice treated with DSS. The disease development observed with ST129 and ST375 colonization was not directly associated with their abundance in the GI tract as their levels did not change throughout DSS treatment, and no major differences in bacterial burden in the gut were observed among the strains tested. Data mining and in vivo neutralization identified IL-6 as a key cytokine responsible for the observed differential disease severity. Collectively, our results show that the capacity to exacerbate acute intestinal inflammation is a strain-specific trait that can potentially be overcome by blocking the pro-inflammatory immune responses that mediate intestinal tissue damage.",
keywords = "Commensal e. coli, Gnotobiotic mice, Interleukin-6, Intestinal inflammation, Strain-specific immune responses",
author = "Hatem Kittana and Gomes-Neto, {Jo{\~a}o Carlos} and Kari Heck and Geis, {Abby L.} and {Segura Mu{\~n}oz}, {Rafael R.} and Cody, {Liz A.} and Schmaltz, {Robert J.} and Bindels, {Laure B.} and Rohita Sinha and Hostetter, {Jesse M.} and Benson, {Andrew K.} and Ramer-Tait, {Amanda E.}",
year = "2018",
month = "10",
day = "9",
doi = "10.3389/fimmu.2018.02318",
language = "English (US)",
volume = "9",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
number = "OCT",

}

TY - JOUR

T1 - Commensal Escherichia coliStrains can promote intestinal inflammation via differential interleukin-6 production

AU - Kittana, Hatem

AU - Gomes-Neto, João Carlos

AU - Heck, Kari

AU - Geis, Abby L.

AU - Segura Muñoz, Rafael R.

AU - Cody, Liz A.

AU - Schmaltz, Robert J.

AU - Bindels, Laure B.

AU - Sinha, Rohita

AU - Hostetter, Jesse M.

AU - Benson, Andrew K.

AU - Ramer-Tait, Amanda E.

PY - 2018/10/9

Y1 - 2018/10/9

N2 - Escherichia coli is a facultative anaerobic symbiont found widely among mammalian gastrointestinal tracts. Several human studies have reported increased commensal E. coli abundance in the intestine during inflammation; however, host immunological responses toward commensal E. coli during inflammation are not well-defined. Here, we show that colonization of gnotobiotic mice with different genotypes of commensal E. coli isolated from healthy conventional microbiota mice and representing distinct populations of E. coli elicited strain-specific disease phenotypes and immunopathological changes following treatment with the inflammatory stimulus, dextran sulfate sodium (DSS). Production of the inflammatory cytokines GM-CSF, IL-6, and IFN-γ was a hallmark of the severe inflammation induced by E. coli strains of Sequence Type 129 (ST129) and ST375 following DSS administration. In contrast, colonization with E. coli strains ST150 and ST468 caused mild intestinal inflammation and triggered only low levels of pro-inflammatory cytokines, a response indistinguishable from that of E. coli-free control mice treated with DSS. The disease development observed with ST129 and ST375 colonization was not directly associated with their abundance in the GI tract as their levels did not change throughout DSS treatment, and no major differences in bacterial burden in the gut were observed among the strains tested. Data mining and in vivo neutralization identified IL-6 as a key cytokine responsible for the observed differential disease severity. Collectively, our results show that the capacity to exacerbate acute intestinal inflammation is a strain-specific trait that can potentially be overcome by blocking the pro-inflammatory immune responses that mediate intestinal tissue damage.

AB - Escherichia coli is a facultative anaerobic symbiont found widely among mammalian gastrointestinal tracts. Several human studies have reported increased commensal E. coli abundance in the intestine during inflammation; however, host immunological responses toward commensal E. coli during inflammation are not well-defined. Here, we show that colonization of gnotobiotic mice with different genotypes of commensal E. coli isolated from healthy conventional microbiota mice and representing distinct populations of E. coli elicited strain-specific disease phenotypes and immunopathological changes following treatment with the inflammatory stimulus, dextran sulfate sodium (DSS). Production of the inflammatory cytokines GM-CSF, IL-6, and IFN-γ was a hallmark of the severe inflammation induced by E. coli strains of Sequence Type 129 (ST129) and ST375 following DSS administration. In contrast, colonization with E. coli strains ST150 and ST468 caused mild intestinal inflammation and triggered only low levels of pro-inflammatory cytokines, a response indistinguishable from that of E. coli-free control mice treated with DSS. The disease development observed with ST129 and ST375 colonization was not directly associated with their abundance in the GI tract as their levels did not change throughout DSS treatment, and no major differences in bacterial burden in the gut were observed among the strains tested. Data mining and in vivo neutralization identified IL-6 as a key cytokine responsible for the observed differential disease severity. Collectively, our results show that the capacity to exacerbate acute intestinal inflammation is a strain-specific trait that can potentially be overcome by blocking the pro-inflammatory immune responses that mediate intestinal tissue damage.

KW - Commensal e. coli

KW - Gnotobiotic mice

KW - Interleukin-6

KW - Intestinal inflammation

KW - Strain-specific immune responses

UR - http://www.scopus.com/inward/record.url?scp=85055329018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055329018&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2018.02318

DO - 10.3389/fimmu.2018.02318

M3 - Article

C2 - 30356663

AN - SCOPUS:85055329018

VL - 9

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - OCT

M1 - 2318

ER -